Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

An Outer Membrane Receptor of Neisseria meningitidis Involved in Zinc Acquisition with Vaccine Potential

Open access

Abstract

Since the concentration of free iron in the human host is low, efficient iron-acquisition mechanisms constitute important virulence factors for pathogenic bacteria. In Gram-negative bacteria, TonB-dependent outer membrane receptors are implicated in iron acquisition. It is far less clear how other metals that are also scarce in the human host are transported across the bacterial outer membrane. With the aim of identifying novel vaccine candidates, we characterized in this study a hitherto unknown receptor in Neisseria meningitidis. We demonstrate that this receptor, designated ZnuD, is produced under zinc limitation and that it is involved in the uptake of zinc. Upon immunization of mice, it was capable of inducing bactericidal antibodies and we could detect ZnuD-specific antibodies in human convalescent patient sera. ZnuD is highly conserved among N. meningitidis isolates and homologues of the protein are found in many other Gram-negative pathogens, particularly in those residing in the respiratory tract. We conclude that ZnuD constitutes a promising candidate for the development of a vaccine against meningococcal disease for which no effective universal vaccine is available. Furthermore, the results suggest that receptor-mediated zinc uptake represents a novel virulence mechanism that is particularly important for bacterial survival in the respiratory tract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1000969

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Regulation of znuD gene expression. Western blots of cell lysates using rabbit antiserum against ZnuD. (A) HB-1 grown in TSB (lane 1), RPMI (lane 2) and the znuD knockout strain grown in RPMI (lane 3). (B) HB-1 grown in RPMI supplemented with 0, 2, 4, 6 and 8% TSB (lanes 1–5, respectively). (C) HB-1 grown in RPMI supplemented with 0, 2, 5, and 10 µM FeCl3 (lanes 1–4, respectively). (D) HB-1 grown in RPMI supplemented with 0, 0.5 or 1 µM ZnSO4 (lanes 1–3, respectively). (E) HB-1 grown in RPMI supplemented with 0, 0.1, 0.5 or 1 µM TPEN (lanes 1–4, respectively). (F) HB-1 (lanes 1–3) and the zur mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 0.6 µM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6).
Figure 1 Regulation of znuD gene expression. Western blots of cell lysates using rabbit antiserum against ZnuD. (A) HB-1 grown in TSB (lane 1), RPMI (lane 2) and the znuD knockout strain grown in RPMI (lane 3). (B) HB-1 grown in RPMI supplemented with 0, 2, 4, 6 and 8% TSB (lanes 1–5, respectively). (C) HB-1 grown in RPMI supplemented with 0, 2, 5, and 10 µM FeCl3 (lanes 1–4, respectively). (D) HB-1 grown in RPMI supplemented with 0, 0.5 or 1 µM ZnSO4 (lanes 1–3, respectively). (E) HB-1 grown in RPMI supplemented with 0, 0.1, 0.5 or 1 µM TPEN (lanes 1–4, respectively). (F) HB-1 (lanes 1–3) and the zur mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 0.6 µM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6).CC BY · PubMed Central
Figure 2 Topology model of ZnuD. The 22 β-strands are colored light grey, the 11 extracellular loops are white and the periplasmic turns are black. The histidine/aspartic acid stretches are boxed. The plug domain was modeled based on known Tdf structures. The amino acid sequence of loop 3 is shown with the cysteines in bold and the His/Asp-rich stretches underlined. Numbers indicate amino acid positions in the sequence of mature ZnuD.
Figure 2 Topology model of ZnuD. The 22 β-strands are colored light grey, the 11 extracellular loops are white and the periplasmic turns are black. The histidine/aspartic acid stretches are boxed. The plug domain was modeled based on known Tdf structures. The amino acid sequence of loop 3 is shown with the cysteines in bold and the His/Asp-rich stretches underlined. Numbers indicate amino acid positions in the sequence of mature ZnuD.CC BY · PubMed Central
Figure 3 Zinc binding and transport by ZnuD. (A) Coomassie-stained SDS-PAGE gels showing the protein content of the OMVs (left) and purified ZnuD preparation (right) used in the PAR-binding assay. OMVs were isolated from strain CE1523 carrying pEN11-znuD that was either induced or not with IPTG for znuD expression as indicated. Purified ZnuD from inclusion bodies (IB ZnuD) was refolded in vitro (Folded ZnuD). The folded ZnuD sample was not heated before SDS-PAGE and the positions of folded and unfolded ZnuD are indicated. (B) Binding of zinc to OMVs either or not containing ZnuD and to purified ZnuD that was either folded or not was measured in a PAR competition assay. Shown are the normalized values of the absorption at 500 nm of five independent measurements. (C) Western blot of whole cell lysates of strain HB-1 (lanes 1–3) and the znuA mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 500 nM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6). (D) Representative growth curves (n = 5) of the znuD and tonB knockout strains and their parent strain in response to zinc limitation. Cultures contained either 0 or 0.3 µM TPEN. (E) Western blot of whole cell lysates of strain HB-1 (lanes 1–2) and the tonB mutant (lanes 3–4) grown in RPMI (lanes 1 and 3) or RPMI with 500 nM ZnSO4 (lanes 2 and 4).
Figure 3 Zinc binding and transport by ZnuD. (A) Coomassie-stained SDS-PAGE gels showing the protein content of the OMVs (left) and purified ZnuD preparation (right) used in the PAR-binding assay. OMVs were isolated from strain CE1523 carrying pEN11-znuD that was either induced or not with IPTG for znuD expression as indicated. Purified ZnuD from inclusion bodies (IB ZnuD) was refolded in vitro (Folded ZnuD). The folded ZnuD sample was not heated before SDS-PAGE and the positions of folded and unfolded ZnuD are indicated. (B) Binding of zinc to OMVs either or not containing ZnuD and to purified ZnuD that was either folded or not was measured in a PAR competition assay. Shown are the normalized values of the absorption at 500 nm of five independent measurements. (C) Western blot of whole cell lysates of strain HB-1 (lanes 1–3) and the znuA mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 500 nM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6). (D) Representative growth curves (n = 5) of the znuD and tonB knockout strains and their parent strain in response to zinc limitation. Cultures contained either 0 or 0.3 µM TPEN. (E) Western blot of whole cell lysates of strain HB-1 (lanes 1–2) and the tonB mutant (lanes 3–4) grown in RPMI (lanes 1 and 3) or RPMI with 500 nM ZnSO4 (lanes 2 and 4).CC BY · PubMed Central
Figure 4 ZnuD synthesis in meningococcal isolates and in vivo. (A) Western blots of cell lysates of the indicated strains grown in RPMI with or without added zinc. a Clonal group designations taken from [40]; –, the strain was typed by Multi-Locus Enzyme Electrophoresis but could not be assigned to a specific clone; ND, not determined. (B) Reaction of human sera with ZnuD on Western blots. The blots contained both native and denatured ZnuD. The specific patient sera used are indicated above the lanes and have been described previously [10], [25]. Also an example of a non-reactive patient serum is shown at the right.
Figure 4 ZnuD synthesis in meningococcal isolates and in vivo. (A) Western blots of cell lysates of the indicated strains grown in RPMI with or without added zinc. a Clonal group designations taken from [40]; –, the strain was typed by Multi-Locus Enzyme Electrophoresis but could not be assigned to a specific clone; ND, not determined. (B) Reaction of human sera with ZnuD on Western blots. The blots contained both native and denatured ZnuD. The specific patient sera used are indicated above the lanes and have been described previously [10], [25]. Also an example of a non-reactive patient serum is shown at the right.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 142

Metadata

Authors
Stork, M., Bos, M. P., Jongerius, I., de Kok, N., Schilders, I., Weynants, V. E., Poolman, J. T., & Tommassen, J.
Affiliations
  • Utrecht University (NL)
  • GlaxoSmithKline (Belgium) (BE)
Corresponding author
Tommassen, Jan
Venue
PLoS Pathogens
Published
2010-07-01
Volume
6
Issue
7
Pages
e1000969
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2045251146
Cited by
141
References
42
Citations by year
2026: 9 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 11 · 2020: 7 · 2019: 10 · 2017: 15 · 2016: 8 · 2015: 10 · 2014: 13 · 2013: 13 · 2012: 12
FWCI
9.99
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
Keywords
Neisseria meningitidis, outer membrane receptor, zinc uptake, vaccine candidate, meningococcal disease, metal transport, zinc limitation, bactericidal antibodies, respiratory tract colonization, virulence factors
MeSH terms
Amino Acid Sequence, Animals, Bacterial Outer Membrane Proteins, Bacterial Proteins, DNA-Binding Proteins, Immunization, Molecular Sequence Data, Neisseria meningitidis, Zinc, Gene Expression Regulation, Bacterial, Meningococcal Vaccines, Cation Transport Proteins, Escherichia coli Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Outer Membrane Receptor of Neisseria meningitidis Involved in Zinc Acquisition with Vaccine Potential. https://app.cochat.ai/papers/10.1371/journal.ppat.1000969
The paper
Stork, M., Bos, M. P., Jongerius, I., de Kok, N., Schilders, I., Weynants, V. E., Poolman, J. T., & Tommassen, J. (2010). An Outer Membrane Receptor of Neisseria meningitidis Involved in Zinc Acquisition with Vaccine Potential. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1000969

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.